Medical Microinstruments (MMI) S.P.A.
At MMI, we believe that life is all about connections. When it comes to performing an anastomosis during a microsurgical procedure, the quality of that connection may even determine if the outcome is successful. The Symani Surgical System is designed to help surgeons connect tiny vessels under 2.0mm in diameter as delicately and precisely as possible. Join us on this journey to make robotic microsurgery a standard of care! Our team has a steadfast dedication to advancing surgery and patient care. We developed Symani, a groundbreaking technology that addresses unmet patient needs and helps to enhance surgeons’ skills during delicate, complex procedures. We’re excited that our innovative solutions will allow more surgeons to perform microsurgical techniques and help expand patient access to supermicrosurgeries for chronic illnesses like lymphedema, a burdensome condition that affects 250 million people around the world.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
Medical Microinstruments, Inc. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery. The Symani Surgical System combines proprietary innovations including the world’s smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies. Together, these powerful capabilities allow more surgeons to successfully perform microsurgery while expanding the field of supermicrosurgery. MMI is backed by international medtech investors including Andera Partners, BioStar, Deerfield Management, Fountain Healthcare Partners, Panakès Partners, RA Capital and Sambatech.
Together, these powerful capabilities work to help enable more surgeons to perform microsurgery while expanding the field of supermicrosurgery.